Gland Pharma Ltd

NSE: GLAND · BSE: 543245 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹2,917.20
Market cap: ₹48,137 Cr
Revenue (annual): ₹6,431 Cr
Net profit (annual): ₹1,027 Cr
P/E (TTM): 42.6×Sector 50.4×
Promoter holding: 51.77%-0.06% QoQ
FII holding: 8.74%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 2 Promoter Selling 1 Merger & Restructuring 1 Legal & Regulatory 1 Employee Stock Options 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Sep 2026 16:27 IST NSE

Acquisition

Gland Pharma Acquisition Worth ₹4.76 Cr

Gland Pharma approved acquiring its step-down subsidiary, Gland Pharma USA Inc., from another wholly-owned subsidiary to streamline corporate structure. The transaction costs USD 5,01,208.

Value: ₹4.76 Cr
Execution: By October 31, 2026

Read the filing ↗